December 19, 2019

Press release - Regulatory

Targovax ASA issues options to employees

November 28, 2019

Press release - Regulatory

Targovax ASA: Primary insider share purchase

November 7, 2019

Press release - Regulatory

Targovax ASA: Third quarter 2019 results

September 18, 2019

Press release - Regulatory

Correction: Targovax Q2 2019 report

August 22, 2019

Press release - Regulatory

Targovax ASA: Second quarter and first half 2019 results

July 9, 2019

Press release - Regulatory

Targovax ASA: Notification of trade by primary insiders

July 8, 2019

Press release - Regulatory

Targovax announces encouraging results from part 1 of the ONCOS-102 and Keytruda combination trial in anti-PD1 refractory melanoma

June 18, 2019

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of RSUs

June 13, 2019

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider following settlement of RSUs

June 12, 2019

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

June 6, 2019

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

June 6, 2019

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

June 5, 2019

Press release - Regulatory

Targovax ASA: Completion of subsequent offering, registration of share capital increase

May 31, 2019

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

May 28, 2019

Press release - Regulatory

Targovax ASA: Final result of the subsequent offering

May 24, 2019

Press release - Regulatory

Targovax ASA: Last day of the subscription period in the subsequent offering

May 23, 2019

Press release - Regulatory

TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS

May 23, 2019

Press release - Regulatory

Targovax to fully focus on ONCOS oncolytic virus program

May 23, 2019

Press release - Regulatory

Targovax announces median and three-year overall survival for TG01 trial in resected pancreatic cancer

May 10, 2019

Press release - Regulatory

Targovax ASA: Commencement of subscription period in the subsequent offering

May 9, 2019

Press release - Regulatory

Targovax ASA: First quarter 2019 results

May 2, 2019

Press release - Regulatory

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

April 30, 2019

Press release - Regulatory

Targovax ASA: Minutes from the Annual General Meeting

April 12, 2019

Press release - Regulatory

TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS

April 9, 2019

Press release - Regulatory

Targovax ASA: Annual Report 2018

April 9, 2019

Press release - Regulatory

Notice of Annual General Meeting

March 28, 2019

Press release - Regulatory

TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

March 27, 2019

Press release - Regulatory

TARGOVAX ASA – APPROVAL AND PUBLICATION OF PROSPECTUS

March 25, 2019

Press release - Regulatory

Targovax to hold a webcast with Q&A session

March 21, 2019

Press release - Regulatory

TARGOVAX ASA – NOTIFICATION OF SHAREHOLDING

March 21, 2019

Press release - Regulatory

TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

March 21, 2019

Press release - Regulatory

TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

March 21, 2019

Press release - Regulatory

TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

March 15, 2019

Press release - Regulatory

Targovax signs clinical collaboration agreement with the Parker Institute for Cancer Immunotherapy and Cancer Research Institute

February 14, 2019

Press release - Regulatory

Targovax ASA: Fourth quarter and full year 2018 results

January 3, 2019

Press release - Regulatory

Targovax ASA issues options to employees